# Dannce.ai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dannce-ai

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.dannce.ai
- Total disclosed funding: $2.6M
- Latest round: Seed (Nov 21, 2024)
- Investors on record: 5

## About

Founded in 2023 by co-founders Rob Baldoni, Timothy Dunn, and Jesse Marshall and based in Massachusetts, US, Dannce.ai is a provider of tools that combine video-based input with 3D pose tracking and deep learning to analyze patient behaviour automatically and in disease diagnosis for neurological and behavioural disorders. In November 2024, Dannce.ai raised USD 2.6 million in pre-seed funding led by investor LDV Capital, with participation from other investors Duke Capital Partners, Glasswing Ventures, Leo Lion Limited, and Merck Digital Sciences Studio.

Dannce.ai’s primary offering is its digital phenotyping platform. This AI-driven tool analyzes behavioural data to detect subtle changes in neurological conditions. For clinicians, the platform provides objective behavioural insights, enabling data-based decision-making and improved patient assessments. For pharmaceutical and biotech companies, Dannce.ai supports clinical trials by offering a sensitive and objective measure of drug effects. The platform's ability to detect efficacy signals reduces trial complexity and increases the ability to identify treatments. 

The company will use the November 2024 funding to support its development and business growth.

## Funding rounds

- Seed, Nov 21, 2024, $2.6M — LDV Capital, Glasswing Ventures, Duke Capital Partners, Leo Lion, Merck Digital Sciences Studio

## Investors

- LDV Capital (https://capitalatlas.ai/funds/ldv-capital) — Seed
- Glasswing Ventures (https://capitalatlas.ai/funds/glasswing-ventures) — Seed
- Duke Capital Partners (https://capitalatlas.ai/funds/duke-capital-partners) — Seed
- Leo Lion (https://capitalatlas.ai/funds/leo-lion) — Seed
- Merck Digital Sciences Studio — Seed